Review the Balance sheet of the latest Walgreen Co. 10k Filing. Select two of the following questions to review/discuss:

1. Which current assets are the most significant? Explain your answer.
2. Which non-current assets are the most significant? Explain your answer.

Item 8. Financial statements and supplementary data WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS At August 31, 2020 and 2019 (in millions, except shares and per share amounts) 2020 2019 $ 516 5 7,132 9,451 974 18,073 1,023 7,226 9,333 1,118 18,700 Assets Current assets: Cash and cash equivalents Accounts receivable, net Inventories Other current assets Total current assets Non-current assets: Property, plant and equipment, net Operating lease right-of-use asset Goodwill Intangible assets, net Equity method investments (see note 5) Other non-current assets Total non-current assets 13,478 13,342 21,724 15,268 10,753 7,338 677 69.101 87,174 $ 16,560 10,876 6,851 1,133 48,899 Total assets s 67,598 S 5,738 14,341 3,538 14.458 2.426 6,539 110 27,070 5,474 216 25,769 11,098 Liabilities and equity Current liabilities: Short-term debt Trade accounts payable (see note 18) Operating lease obligation Accrued expenses and other liabilities Income taxes Total current liabilities Non-current liabilities: Long-term debt Operating lease obligation Deferred income taxes Other non-current liabilities - Total non-current liabilities Commitments and contingencies (see note 10) Equity: Preferred stock 8.01 par value, authorized 32 million shares, none issued Common stock 8.01 par value, authorized 3.2 billion shares; issued 1,172,513,618 at August 31, 2020 and 2019 Paid-in capital Retained earnings Accumulated other comprehensive loss Treasury stock, at cost, 306,910,099 shares at August 31, 2020 and 277,126,116 shares at August 31, 2019 Total Walgreens Boots Alliance, Inc. shareholders' equity Noncontrolling interests Total equity Total liabilities and equity 12.203 21,973 1.498 3,294 38,968 1,785 4,795 17,678 12 10,761 34,210 (3,771) (20,575) 20,637 498 21.136 87,174 $ 12 10.639 35,815 (3,897) (19.057) 23,512 641 24,152 67,598 S The accompanying notes to Consolidated Financial Statements are an integral part of these Statements